This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 21 Dec 2016  |  Africa  |  Market Research

    African Pharmaceuticals Market, Forecast to 2020

    Assessing Market Potential with a Focus on Kenya and Nigeria

    The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest re...

    $4,950.00
  2. 11 Nov 2016  |  North America  |  Market Research

    Global Orphan Drug Market

    High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs

    The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

    $6,000.00
  3. 08 Nov 2016  |  North America  |  Market Research

    The US Molecular Diagnostics Market, Forecast to 2021

    Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye

    The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...

    $4,950.00
  4. 13 Sep 2016  |  North America  |  Market Research

    US Next-generation Sequencing Services Market

    $1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

    The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

    $4,950.00
  5. 25 Jul 2016  |  North America  |  Market Research

    US Hospital Cybersecurity Market—2015–2021

    Healthcare Gears Up to Combat the Growing Risk of Cyber Attacks

    The report describes and defines the market for various types of solutions (products and services) deployed by US hospitals to protect the security of enterprise information technology (IT) systems and the privacy and security of patient information; covers key factors driving the need to deploy these solutions in response to dynamic industry shift...

    $4,950.00
  6. 08 Jul 2016  |  North America  |  Market Research

    Digital Health Grows Up- Is Pharma Guiding the Way?

    Frost & Sullivan reviews key themes and industry trends from the 5th Annual Digital Health Summer Summit and BIO International held in June 2016. Major topics covered include the use of virtual and augmented reality in medical education and clinical care; new digital health technologies to improve mental health; investor perspectives on the market ...

    $1,500.00
  7. 23 Jun 2016  |  North America  |  Market Research

    Healthcare Wearables—5 Strategies to Avoid in Development

    With regards to wearables and healthcare, strong customer demand and surging sales are only part of the story. The other side of the narrative captures the tale of a highly volatile marketplace where, due to intense competition, there is a revolving door of company entries and exits. Accordingly, Frost & Sullivan’s team, through its tracking of w...

    $1,500.00
  8. 23 Jun 2016  |  North America  |  Market Research

    Growth Opportunities in the US Point-of-care Testing Market

    Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

    The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

    $4,950.00
  9. 13 Jun 2016  |  North America  |  Market Research

    Top Trends in Telehealth from ATA 2016

    Strong Growth Opportunities amidst the Undertow of Controversy

    The American Telemedicine Association held its annual conference in Minneapolis from May 14 to 17, 2016. This event has become the premier gathering for healthcare professionals, technology innovators, and journalists to attend presentations of key opinion leaders and see the latest telemedicine products on display in an exhibit hall. The highlig...

    $1,500.00
  10. 27 May 2016  |  Africa  |  Market Research

    Pharmaceutical Market Access Strategy for Ethiopia

    Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain

    Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

    $4,950.00